CDC's Advisory Committee on Immunization Practices Meeting
What
Meeting of the Advisory Committee on Immunization Practices (ACIP)
When
October 24-25, 2012
Where
Centers for Disease Control and Prevention 1600 Clifton Road NE Atlanta, GA 30329 Tom Harkin Global Communications Center (Building 19) Room 232 For directions to CDC, please visit http://www.cdc.gov/about/resources/visitGuide.htm#direction
Webstream
If you cannot attend the meeting in person, it will be webstreamed. More information can be found at http://www.cdc.gov/vaccines/acip/meetings/downloads/webcast-instructions.pdf [PDF - 180KB]
Background
An agenda for the meeting can be found at http://www.cdc.gov/vaccines/acip/index.html
The Advisory Committee on Immunization Practices (ACIP) consists of 15 experts in fields associated with immunization who have been selected by the Secretary of the U. S. Department of Health and Human Services to provide advice and guidance to the Secretary, the Assistant Secretary for Health, and the Centers for Disease Control and Prevention (CDC) on the control of vaccine-preventable diseases.
The committee develops written recommendations for the routine administration of vaccines to children and adults in the civilian population; recommendations include age for vaccine administration number of doses and dosing interval, and precautions and contraindications.
Special Note: Reporters who wish to attend the meeting in person must RSVP to Tom Skinner in CDC’s Division of News & Electronic Media (tskinner@cdc.gov) by COB on Tuesday, October 23rd. Space is limited and only those reporters who RSVP will be guaranteed working space during the meeting.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.